Report of a novel kindred with antithrombin heparin-binding site variant (47 Arg to His): Demand for an automated progressive antithrombin assay to detect molecular variants with low thrombotic risk [7]

Thrombosis and Haemostasis

Volumn 98, Issue 3, 2007, Pages 695-697

  Rossi, Elena ^a   Chiusolo, Patrizia ^a   Za, Tommaso ^a   Marietti, Sara ^a   Ciminello, Angela ^a   Leone, Giuseppe ^a   De Stefano, Valerio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; ARGININE; DNA; HEPARIN; HISTIDINE;

ADULT; ANALYTICAL EQUIPMENT; AUTOMATION; BINDING SITE; CASE REPORT; CEREBROVASCULAR ACCIDENT; CODON; EXON; FEMALE; HEART INFARCTION; HETEROZYGOSITY; HOMOZYGOTE; HUMAN; LETTER; MENSTRUATION DISORDER; NUCLEIC ACID BASE SUBSTITUTION; PATIENT COUNSELING; PATIENT REFERRAL; PRIORITY JOURNAL; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ANTITHROMBIN III; ANTITHROMBIN III DEFICIENCY; AUTOMATION; BINDING SITES; BLOOD COAGULATION TESTS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEPARIN; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MOLECULAR WEIGHT; MUTATION, MISSENSE; PEDIGREE; RISK ASSESSMENT; RISK FACTORS; THROMBOSIS;

EID: 34548701083     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-01-0067     Document Type: Letter

References (15)

1. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood 1996; 87: 3531-3544.
2. Lane DA, Bayston T, Olds RJ, et al. Antithrombin mutation database: 2nd (1997) update. Thromb Haemost 1997; 77: 197-211.
3. Lane DA, Olds RR, Thein SL. Antithrombin and its deficiency states. Blood Coagul Fibrinolysis 1992; 3: 315-341.
4. Finazzi G, Caccia R, Barbui T. Different prevalence of thromboembolism in the subtypes of corlgenital anti-thrombin III deficiency: review of 404 cases. Thromb Haemost 1987; 58: 1094.
5. Girolami A, Lazzaro AR, Simioni P. The relationship between detective heparin cofactor activities and thrombotic phenomena in AT III abnormalities. Thromb Haemost 1988; 59: 121.
6. Wells PS, Blajchman MA, Henderson P, et al. Prevalence of antithrombin deficiency in healthy blood donors: a cross-sectional study. Am J Hematol 1994; 45: 321-324.
7. McColl M, Tait RC, Walker ID, et al. Low thrombosis rate seen in blood donors and their relatives with inherited deficiencies of antithrombin and protein C: correlation with type of defect, family history, and absence of the factor V Leiden mutation. Blood Coagul Fibrinolysis 1996; 7: 689-694.
8. Tripodi A, Mannucci PM. Laboratory investigation of thrombophilia. Clin Chem 2001; 47: 1597-606.
9. Odegard OR, Lie M, Abildgaard U. Antifactor Xa activity measured with amidolytic methods. Haemostasis 1976; 5: 265-275.
10. Abildgaard U, Fagerhol MK, Egeberg O. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in human plasma. Scand J Clin Lab Invest 1970; 26: 349-354.
11. Huang ZF, Wun TC, Broze GJ, Jr. Kinetics of factor Xa inhibition by tissue factor pathway inhibitor. J Biol Chem 1993; 268: 26950-26955.
12. Picard V, Bauters A, Khairy M, et al. Conformational Asn 187 Asp / Lys antithrombin variants and thrombosis. Clinical and biological features in 13 new heterozygotes. Thromb Haemost 2005; 93: 57-62.
13. Owen MC, Borg JY, Soria C, Soria J, Carrell RW. Heparin binding defect in a new antithrombin III variant: Rouen, 47 Arg to His. Blood 1987; 69: 1275-1279.
14. Wolf M, Boyer-Neumann C, Molho-Sabatier P, Neumann C, Meyer D, Larrieu MJ. Familial variant of antithrombin III (AT III Bligny, 47Arg to His) associated with protein C deficiency Thromb Haemost 1990; 63: 215-219.
15. Caso R, Lane DA, Thompson E, et al. Antithrombin Padua I: impaired heparin binding caused by an Arg 47 to His (CGT to CAT) substitution. Thromb Res 1990; 58: 185-190.